{
  "query": "sanctions against company name",
  "timestamp": "2025-09-06 08:05:26",
  "config": {
    "top_k": 5,
    "similarity_threshold": 0.0,
    "reranking_enabled": true,
    "hybrid_search_enabled": true,
    "hybrid_search_weight": 0.7
  },
  "results": [
    {
      "id": 1,
      "text": "es. The Company cannot \nguarantee \nthat \nthe \ndefection \nof \ncertain \nemployees will not have a negative impact on its \nintellectual property rights. Legal risk \nSome contracts may contain warranties or \npenalties which generally represent only a few \npercent of the amount of the contract in the case \nof conventional sales contracts. However, these \namounts may be significantly higher in public-\nprivate partnerships inasmuch as the penalties \nmust cover the associated financing. Such \nclauses are applicable only to a limited number \nof contracts, essentially those relating to proton \ntherapy projects.",
      "similarity_score": 0.05144045594788523,
      "metadata": {
        "filename": "annual_report_text (1).txt",
        "filepath": "input\\annual_report_text (1).txt",
        "chunk_id": 239,
        "start_char_idx": 0,
        "end_char_idx": 0,
        "page": null,
        "section": null
      }
    },
    {
      "id": 2,
      "text": "munication of critical concerns \np51 AR2023 Management report / principal risks and uncertainties faced by the \ncompany \np80 AR2023 Management report / corporate governance statement / codes of \nconduct",
      "similarity_score": 0.04944454204462726,
      "metadata": {
        "filename": "annual_report_text (1).txt",
        "filepath": "input\\annual_report_text (1).txt",
        "chunk_id": 1050,
        "start_char_idx": 0,
        "end_char_idx": 0,
        "page": null,
        "section": null
      }
    },
    {
      "id": 3,
      "text": "ties are accessible \nto persons with reduced mobility. As an example, the four main buildings in Louvain-la-Neuve are \nfully adapted for such people. If necessary, a \nconstructive discussion is held with the person \nwith reduced mobility in order to guarantee him \nor her a workspace where he or she can move \naround as independently as possible. Risks and Risk Management \nThe risks and risk management of the protection \nand respect of Human Rights are described \nabove, in the dedicated Section Principal Risks \nand Uncertainties faced by the Company \n(Sections 3:6, 1, 1 to 3 and 3:32, 1, 1 to 3, of the BCAC). === Page 90 ===\nIBA Annual Report 2023 \n87.",
      "similarity_score": 0.053111857022957065,
      "metadata": {
        "filename": "annual_report_text (1).txt",
        "filepath": "input\\annual_report_text (1).txt",
        "chunk_id": 459,
        "start_char_idx": 0,
        "end_char_idx": 0,
        "page": null,
        "section": null
      }
    },
    {
      "id": 4,
      "text": "=== Page 22 ===\nA COMBINATION OF DIAGNOSIS AND \nTHERAPY: THERANOSTICS\nRadiotheranostics is a type of cancer treatment that combines \ndiagnostic imaging with targeted radiation therapy. It involves \nthe use of radiopharmaceuticals, which are compounds that \ncontain both a radioactive isotope and a targeting molecule. These radiopharmaceuticals are injected into the patients \nbloodstream and travel to cancer cells, where they can be \ndetected using imaging techniques such as PET or SPECT. Once the cancer cells have been identified, the same \nradiopharmaceutical can be used to deliver a targeted dose \nof radiation to the cancer cells, killing them while sparing \nhealthy tissues.",
      "similarity_score": 0.053073534483783,
      "metadata": {
        "filename": "annual_report_text (1).txt",
        "filepath": "input\\annual_report_text (1).txt",
        "chunk_id": 70,
        "start_char_idx": 0,
        "end_char_idx": 0,
        "page": null,
        "section": null
      }
    },
    {
      "id": 5,
      "text": "and 7:202 (public takeover bid) of the [Belgian] \nCompanies & Associations Code (hereafter, the \nBCAC). === Page 73 ===\nIBA Annual Report 2023 \n70. IBA \nREMUNERATION REPORT (SECTION 3:6, 3, OF THE \nBCAC) \nRemuneration Policy: Managing \nDirectors and other Executive \nManagement Team Members \nProcedure",
      "similarity_score": 0.05148248317893971,
      "metadata": {
        "filename": "annual_report_text (1).txt",
        "filepath": "input\\annual_report_text (1).txt",
        "chunk_id": 351,
        "start_char_idx": 0,
        "end_char_idx": 0,
        "page": null,
        "section": null
      }
    }
  ]
}